Literature DB >> 25401994

Jak2 mutation-positive polycythemia vera presenting as central retinal artery occlusion.

Elona Dhrami-Gavazi1, Winston Lee, Jason D Horowitz, Jeffrey Odel, Sri Krishna Mukkamala, Dana M Blumberg, Michael Weiss, Bryan J Winn.   

Abstract

PURPOSE: To report the case of a 49-year-old man who presented with profound visual loss in his right eye because of a central retinal artery occlusion, accompanied by a stroke in the ipsilateral middle cerebral artery with left upper extremity sequelae.
METHODS: The patient underwent a comprehensive ophthalmologic examination, fluorescein angiography, thorough neuroophthalmology evaluation, including magnetic resonance imaging and magnetic resonance angiography, 12-lead electrocardiogram, transesophageal echocardiogram, bilateral carotid artery Doppler, Holter monitoring, comprehensive laboratory testing, bone marrow biopsy, and genetic testing.
RESULTS: Despite an initially normal hematocrit, the etiology of the central retinal artery occlusion and that of the nearly concomitant stroke in the right medial cerebral artery territory was confirmed by bone marrow biopsy to be polycythemia vera (positive JAK2 mutation). Patient received treatment with aspirin, serial phlebotomies, and hydroxyurea, demonstrating a slight improvement in vision and substantial normalization of neurologic and hematological status. At the time of this report, 2 years later, patient remains stable.
CONCLUSION: Central retinal artery occlusion, a disease with a frequently devastating visual outcome, is often not an "isolated" ocular occurrence. In the absence of an obvious local trigger, a thorough work-up is always warranted, especially in younger patients, as the ocular pathology oftentimes may herald severe cerebro-cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25401994     DOI: 10.1097/ICB.0000000000000114

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  2 in total

1.  Central retinal artery occlusion as a presenting manifestation of polycythaemia vera.

Authors:  Karthik Rao; Shailaja Bhat Shenoy; Yogish Kamath; Smita Kapoor
Journal:  BMJ Case Rep       Date:  2016-10-20

2.  Subretinal fluid accumulation in a patient with polycythemia vera after receiving a prostaglandin I2 analogue treatment.

Authors:  Tomoko Noda; Kousuke Noda; Kiriko Hirooka; Satoru Kase; Susumu Ishida
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.